When myasthenia gravis is deemed refractory: clinical signposts and treatment strategies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

When myasthenia gravis is deemed refractory: clinical signposts and treatment strategies

Published:2018-01 Issue: Volume:11 Page:175628561774913
ISSN:1756-2864
Container-title:Therapeutic Advances in Neurological Disorders
language:en
Short-container-title:Ther Adv Neurol Disord

Author:

Mantegazza Renato¹,Antozzi Carlo²

Affiliation:

1. Department of Neuroimmunology and Neuromuscular Diseases, Fondazione Istituto Neurologico Carlo Besta, Via Celoria, 11, 20133 Milan, Italy

2. Department of Neuroimmunology and Neuromuscular Diseases, Fondazione Istituto Neurologico Carlo Besta, Milan, Italy

Publisher

SAGE Publications

Subject

Neurology (clinical),Neurology,Pharmacology

Link

http://journals.sagepub.com/doi/pdf/10.1177/1756285617749134

Reference37 articles.

1. Myasthenia gravis

2. Myasthenia gravis: Newer therapies offer sustained improvement

3. Lifetime course of myasthenia gravis

4. THE NATURAL COURSE OF MYASTHENIA GRAVIS AND EFFECT OF THERAPEUTIC MEASURES

5. Complete stable remission and autoantibody specificity in myasthenia gravis

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myasthenia gravis - diagnostischer Workup und neue Therapien;DNP – Die Neurologie & Psychiatrie;2024-08

2. Characterizing Myasthenia Gravis Symptoms, Exacerbations, and Crises From Neurologist's Clinical Notes Using Natural Language Processing;Cureus;2024-07-30

3. Therapeutic challenges and unmet needs in the management of myasthenia gravis: an Italian expert opinion;Neurological Sciences;2024-07-05

4. Targeting autoimmune mechanisms by precision medicine in Myasthenia Gravis;Frontiers in Immunology;2024-06-06

5. Increased serum interleukin-41 correlates with disease severity in myasthenia gravis;International Immunopharmacology;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3